|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
B
|
|
INDICATIONS:
|
|
Echocardiography, adjunct |
| |
|
|
SIDE EFFECTS:
|
|
Allergic reaction |
|
chest pain |
|
dyspnea |
|
Dizziness |
|
flushing of skin or sensation of warmth |
|
headache |
|
nausea and/or vomiting |
|
Changes in taste |
|
dryness of mouth |
|
fatigue |
|
pain at injection site |
|
weakness |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
>> Cardiac shunt, right-to-left, bidirectional, or transient right-to-left |
|
>> Heart defects, congenital |
|
>> Hepatic function impairment, severe |
|
Pulmonary disease, especially emphysema, pulmonary vasculitis, or history of pulmonary emboli |
|
Respiratory distress syndrome |
|
|
ADULT DOSE:
|
|
Cardiac imaging, ultrasound-Intravenous, 0.5 mL into a peripheral vein, administered at a rate not to exceed 1 mL per second .
Note: The injection of the octafluoropropane-containing human albumin microspheres should be followed by a rapid flush with 0.9% sodium chloride injection or 5% dextrose injection .
If contrast enhancement is not adequate after administration of a 0.5 mL-dose, a dose of 3 mL may be injected after 10 minutes .
A third injection of 5 mL, 10 minutes after the second dose, may be used if needed for adequate contrast enhancement . |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Safety and efficacy have not been established .
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
Cardiac imaging, ultrasound-Intravenous, 0.5 mL into a peripheral vein, administered at a rate not to exceed 1 mL per second .
Note: The injection of the octafluoropropane-containing human albumin microspheres should be followed by a rapid flush with 0.9% sodium chloride injection or 5% dextrose injection .
If contrast enhancement is not adequate after administration of a 0.5 mL-dose, a dose of 3 mL may be injected after 10 minutes .
A third injection of 5 mL, 10 minutes after the second dose, may be used if needed for adequate contrast enhancement . |
|
|
|
|
|